Thursday, April 15, 2021
Home 2020 September

Monthly Archives: September 2020

CB Scientific
Telehealth

Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.

Editor / Curator -
Dalrada
Biotech News

Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.

Editor / Curator -
Hapbee, Biotech Stock Review
Biotech News

Video: Hapbee Testimonials.

Editor / Curator -
Interview

Citius Pharma (CTXR) Video Presentation.

Editor / Curator -
Compass Pathways, Biotech Stock Review
IPOS

Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.

Editor / Curator -
Stand Down.

Fed President, Neel Kashkari: Ending Privatized Profits and Socialized Losses.

Editor / Curator -
Biotech Stocks
Telehealth

Telehealth: How the Pandemic Forced Mental Health Care to Change for...

Editor / Curator -
Sorrento Theraputics, Biotech STock Review
Superbug News - CoronaVirus Watch List

Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.

Editor / Curator -
IPOS

Snowflake (SNOW) vs Facebook (FB) IPO.

Editor / Curator -
Telehealth

Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the...

Editor / Curator -
123Page 1 of 3

Latest article

Tiki Hut 7

Seven of the World’s Top Performing Stocks, Every Morning

Uncategorized Editor / Curator -
THE TIKI HUT FUND | TODAY'S 7 BIGGEST MOVERS

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

All News Editor / Curator -
Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
CB Scientific, Biotech Stock Review, Telehealth

My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

Telehealth Editor / Curator -
New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.